Tonsilgon N tab. p / o No. 50

Release form

Tonsilgon.

Dragee light blue, round, biconvex.

pharmachologic effect

Herbal antiseptic.

Pharmacological properties are due to biologically active substances that make up the drug.

Tonsilgon N has anti-inflammatory and antiseptic properties.

The active components of chamomile, marshmallow and horsetail included in the preparation help to increase the activity of nonspecific factors of the body's defense.

Polysaccharides, essential oils and flavonoids of chamomile, marshmallow and yarrow, oak bark tannins have an anti-inflammatory effect and help reduce swelling of the respiratory tract mucosa.

Indications

Acute and chronic diseases of the upper respiratory tract (tonsillitis, pharyngitis, laryngitis).

Prevention of complications in respiratory viral infections and as an addition to antibiotic therapy for bacterial infections.

Contraindications

Hypersensitivity to the components of the preparation, in particular, to plants of the Asteraceae family

children under 6 years old

for patients with a rare hereditary form of lactose intolerance, fructose intolerance, lactase deficiency, glucose-galactose malabsorption or sucrase-isomaltase deficiency, the use of the drug is contraindicated (due to the content of lactose and sucrose in the drug).

Application during pregnancy and lactation

The use of the drug is possible if the potential benefit to the mother outweighs the potential risk to the fetus and child.

A doctor's consultation is required.

special instructions

If, when using the drug for 7 days, the symptoms of the disease persist or the patient's condition worsens, you should consult a doctor.

One dragee contains less than 0.03 bread units" (XE).

Impact on the ability to drive vehicles and other mechanisms that require increased concentration

The use of the drug does not affect the ability to perform potentially hazardous activities requiring increased concentration of attention and speed of psychomotor reactions.

Structure

1 tablet contains:

Active ingredients: Marshmallow roots 8.0 mg, Chamomile flowers 6.0 mg, Horsetail herb 10.0 mg, Walnut leaves 12.0 mg, Yarrow herb 4.0 mg, Oak bark 4.0 mg, Dandelion herb 4 , 0 mg.

Excipients: lactose 51.523 mg, maize starch 23.290 mg, potato starch 5.858 mg, stearic acid 2.600 mg, glucose monohydrate 0.929 mg, highly dispersed silicon dioxide 0.650 mg.

Dragee coating: calcium carbonate 4.339 mg, glucose syrup 1.536 mg, indigotin 0.002 mg, maize starch 1.240 mg, modified maize starch 3.785 mg, montan glycol wax 0.130 mg, poly (1-vinyl-2-pyrrolidone) K 25 0.112 mg, poly (1-vinyl-2-pyrrolidone) K 30 0.246 mg, castor oil 0.057 mg, sucrose 62.198 mg, shellac 1.476 mg, talc 52.687 mg, highly dispersed silicon dioxide 0.986 mg, titanium dioxide 1.206 mg.

Method of administration and dosage

Inside.

Dragee is swallowed whole, without chewing, if necessary, washed down with water.

In the acute period of the development of the disease

Adults: 2 tablets 5 - 6 times a day.

School-age children (over 6 years old): 1 tablet 5-6 times a day.

After the disappearance of acute symptoms of the disease (sore throat), treatment with the drug should be continued for another 1 week.

After the disappearance of acute symptoms

Adults: 2 tablets 3 times a day.

School-age children (over 6 years old): 1 tablet 3 times a day.

Side effects

From the gastrointestinal tract are possible: nausea, vomiting.

Possible: allergic reactions.

If signs of an allergic reaction appear, you should stop taking the drug.

Drug interactions

The combination with antibacterial drugs is possible and advisable.

Interaction with other medicinal products has not been described.

Overdose

To date, no cases of overdose have been reported.

Symptoms: in case of an overdose, side effects from the gastrointestinal tract may increase.

Treatment: symptomatic.

Storage conditions

The drug should be stored in a dry, dark place, out of the reach of children, at a temperature not exceeding 25 ° C.

Shelf life

3 years.

Active substance

Althea kor., Chamomile color., Horsetail tr., Gretz.

walnut leaf, Yarrow tr., Oak bark., Dandelion tr.

Name ENG

TONSILGON N

Clinical and pharmacological group

Plant antiseptic

ATX code

Other drugs

Dosage

1 tablet: Althea roots 8.0 mg, Chamomile flowers 6.0 mg, Horsetail herb 10.0 mg, Walnut leaves 12.0 mg, Yarrow herb 4.0 mg, Oak bark 4.0 mg, Dandelion herb 4 , 0 mg.

Structure

1 tablet contains: Active ingredients: Marshmallow roots 8.0 mg, Chamomile flowers 6.0 mg, Horsetail grass 10.0 mg, Walnut leaves 12.0 mg, Yarrow grass 4.0 mg, Oak bark 4.0 mg, Dandelion herb 4.0 mg. Excipients: lactose 51.523 mg, maize starch 23.290 mg, potato starch 5.858 mg, stearic acid 2.600 mg, glucose monohydrate 0.929 mg, highly dispersed silicon dioxide 0.650 mg Dragee shell, calcium carbonate 4.339 mg syrup 1.536 mg, indigotin 0.002 mg, maize starch 1.240 mg, modified maize starch 3.785 mg, montan glycol wax 0.130 mg, poly (1-vinyl-2-pyrrolidone) K 25 0.112 mg, poly (1-vinyl-2-pyrrolidone) K 30 0.246 mg, castor oil 0.057 mg, sucrose 62.198 mg, shellac 1.476 mg, talc 52.687 mg, highly dispersed silicon dioxide 0.986 mg, titanium dioxide 1.206 mg.

Indications

Acute and chronic diseases of the upper respiratory tract (tonsillitis, pharyngitis, laryngitis). Prevention of complications in respiratory viral infections and as an addition to antibiotic therapy for bacterial infections.

INN / Active ingredient

Marshmallow roots, Chamomile flowers, Horsetail herb, Walnut leaves, Yarrow herb, Oak bark, Dandelion herb

Storage conditions and periods

At a temperature not exceeding 25 degrees, in the original packaging.

Expiration date: 3 years

Contraindications

hypersensitivity to the components of the preparation, in particular, to plants of the Asteraceae family

children under 6 years old

for patients with a rare hereditary form of lactose intolerance, fructose intolerance, lactase deficiency, glucose-galactose malabsorption or sucrase-isomaltase deficiency, the use of the drug is contraindicated (due to the content of lactose and sucrose in the drug).

Specifications

Scope of the medicinal product

The immune system

Release form

Tablet

Manufacturer country

Germany

Package quantity, pcs

fifty

Scope of application

Pulmonology

Minimum age from

6 years

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Bionorica

The amount of the dosage form in the primary package

25 pcs.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Herbal immunostimulating agent

Anatomical and therapeutic characteristics

R02AA20 Other antiseptics

Dosage form

Film-coated tablets

Packaging

Cardboard box

The target audience

Children

Expiration date in days

1095

Package weight, g

45

Category

:

Antibiotics

,

Antiseptics and disinfectants

,

Disinfectants

Mode of application

:

Inside.

Dragees are swallowed whole, without chewing, washed down with water if necessary. < br> In the acute period of the development of the disease. Adults: 2 tablets 5 - 6 times a day. < br> School-age children (over 6 years old): 1 tablet 5 - 6 times a day. < br> After the disappearance of acute symptoms of the disease (sore throat), you should continue treatment with the drug for another 1 week. < br> After the disappearance of acute symptoms < br> Adults: 2 tablets 3 times a day. < br> Children of school age (over 6 years old): 1 tablet 3 times a day. < br>

Dosage (volume) of the substance in the preparation

:

1 tablet: Althea roots 8.0 mg, Chamomile flowers 6.0 mg, Horsetail herb 10.0 mg, Walnut leaves 12.0 mg, Yarrow herb 4.0 mg, Oak bark 4.0 mg, Dandelion herb 4 , 0 mg.

Information on technical characteristics, delivery set, country of manufacture "